KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity (2016 - 2025)

Historic Return on Equity for Medpace Holdings (MEDP) over the last 10 years, with Q4 2025 value amounting to 1.2%.

  • Medpace Holdings' Return on Equity rose 7200.0% to 1.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.2%, marking a year-over-year increase of 7200.0%. This contributed to the annual value of 0.7% for FY2025, which is 1200.0% up from last year.
  • As of Q4 2025, Medpace Holdings' Return on Equity stood at 1.2%, which was up 7200.0% from 1.86% recorded in Q3 2025.
  • Medpace Holdings' 5-year Return on Equity high stood at 1.86% for Q3 2025, and its period low was 0.19% during Q1 2021.
  • Its 5-year average for Return on Equity is 0.61%, with a median of 0.53% in 2023.
  • As far as peak fluctuations go, Medpace Holdings' Return on Equity tumbled by -2500bps in 2024, and later skyrocketed by 14100bps in 2025.
  • Medpace Holdings' Return on Equity (Quarter) stood at 0.2% in 2021, then surged by 239bps to 0.67% in 2022, then dropped by -18bps to 0.55% in 2023, then decreased by -14bps to 0.47% in 2024, then skyrocketed by 153bps to 1.2% in 2025.
  • Its Return on Equity stands at 1.2% for Q4 2025, versus 1.86% for Q3 2025 and 1.09% for Q2 2025.